Jin Yang

Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial

Binghe Xu, Min Yan, Fei Ma et al. · The Lancet Oncology · 2021 · 393 citations

Medicine, Oncology, Pharmacology +16

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Rury R. Holman, Ruth L. Coleman, Juliana C.N. Chan et al. · The Lancet Diabetes & Endocrinology · 2017 · 320 citations

Medicine, Cardiology, Pharmacology +16

Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial

Fei Ma, Min Yan, Wěi Li et al. · BMJ · 2023 · 84 citations · Full text

Medicine, Oncology, Pharmacology +17

Enhanced recovery after surgery for radical cystectomy with ileal urinary diversion: a multi-institutional, randomized, controlled trial from the Chinese bladder cancer consortium

Tianxin Lin, Kaiwen Li, Hao Liu et al. · World Journal of Urology · 2017 · 60 citations

Medicine, Surgery, Urology +14

The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients

Jiaqiang Dan, Jinya Tan, Junhua Huang et al. · Breast Cancer · 2020 · 47 citations

Medicine, Oncology, Pathology +12